团体认知行为治疗对强迫症患者生存质量的影响

目的 观察团体认知行为治疗改善强迫症患者生存质量的临床疗效.方法 将81例强迫症患者随机分为研究组40例(帕罗西汀+团体认知行为治疗)和对照组41例(帕罗西汀治疗),疗程14周.采用耶鲁-布朗强迫量表(Y-BOCS)、世界卫生组织生存质量量表(WHOQOL)评定临床疗效.结果 治疔14周后两组Y-BOCS均明显下降,两组下降幅度相比差异无显著性(P＞0.05).WHOQOL量表评分水平较治疗前有显著改善,且治疗后研究组低于对照组(P＜0.05).结论 团体认知行为联合帕罗西汀治疗和单纯帕罗西汀药物治疗均能改善强迫症状,但联合治疗能明显改善强迫症患者的生存质量.

Cognitive-behavioral therapy in groups on the quality of life of patients with obsessive-compulsive disorder

Objective To observe cognitive behavioral therapy in groups to improve the clinical efficacy of the quality of life of patients with obsessive-compulsive disorder. Methods 81 cases of obsessive-compulsive disorder patients were randomly divided into study group （Paroxetine therapy ＋ cognitive behavioral therapy in groups） and control group （Paroxetine）, 40 cases for study group, 41 cases in control group, 14 weeks of treatment. The Yale-Brown Obsessive Compulsive Scale （Y-BOCS） and the World Health Organization Quality of Life Scale （WHOQOL） were used to assess the clinical efficacy. Results At the end of treatment of 14 weeks Y-BOCS of two groups were all significantly decreased, there were no significant difference in the two groups （P〉0.05）. The improving level of WHOQOL Scale scores was better than that before treatment with statistical significance, and the study group lower than the control group （P〈0.05）. Conclu- sions Combination therapy and simple Paroxetine drug therapy can all improve obsessive-compulsive symptoms, but Paroxetine medication at the same joint cognitive behavior therapy in groups can significantly improve the quality of life of patients with obsessive-compulsive disorder.